The FDA announced that it's reviewing the safety of a class of prostate cancer drugs, following up on data that suggest an increased risk of diabetes and certain heart problems. The agency is sifting ...
Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men in the U.S. The American Cancer Society estimates there were 192,000 new cases last year ...
SALT LAKE CITY—Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research introduced at SNM's 57th Annual Meeting demonstrates how a novel peptide-targeted imaging ...
A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Alexander Chehrazi-Raffle, MD, discusses ...
A large international study has shown that an MRI scan can reduce the number of invasive prostate biopsies by up to 28%. The PRECISION trial shows that using MRI to target prostate biopsies leads to ...
It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...
As interdisciplinary collaborators at Wayne State University, the School of Medicine’s Sheryl Roberts, Ph.D., left, and College of Liberal Arts and Sciences’ Christopher Kelly, Ph.D., are advancing ...
WASHINGTON (Reuters) - U.S. regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines. The Food and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback